Results 41 to 50 of about 44,651 (208)

MicroRNA expression, survival, and response to interferon in liver cancer [PDF]

open access: yes, 2009
BACKGROUND: Hepatocellular carcinoma is a common and aggressive cancer that occurs mainly in men. We examined microRNA expression patterns, survival, and response to interferon alfa in both men and women with the disease.
Ambs, S   +18 more
core   +1 more source

Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis [PDF]

open access: yes, 2020
Aim: A study was conducted to evaluate the ameliorative potential of homeopathic drugs in combination (Sulfur 30C, Thuja 30C, Graphites 30C, and Psorinum 30C) in 16 dogs affected with oral papillomatosis which was not undergone any previous treatment ...
Kumar, M. Asok   +5 more
core   +2 more sources

Using Recombinant Interferon Alpha-2b in Pediatric Practice

open access: yesZdorovʹe Rebenka, 2016
Interferon system is a key element of antiviral defense of the child’s body that etiopathogenetically justifies the use of nasal and rectal formulations of recombinant interferon alfa-2b for the prevention and treatment of acute respiratory viral ...
Yu.V. Marushko   +2 more
doaj   +1 more source

The chronic myeloid leukemia stem cell: stemming the tide of persistence [PDF]

open access: yes, 2017
Chronic myeloid leukaemia (CML) is caused by the acquisition of the tyrosine kinase BCR-ABL1 in a haemopoietic stem cell (HSC), transforming it into a leukaemic stem cell (LSC) that self-renews, proliferates and differentiates to give rise to a ...
Holyoake, Tessa L., Vetrie, David
core   +1 more source

National Institute for Clinical Excellence and its value judgments [PDF]

open access: yes, 2004
The National Institute for Clinical Excellence (NICE) offers health professionals in England and Wales advice on providing NHS patients with the highest attainable standards of care.
Culyer, A.J., Rawlins, M.D.
core   +2 more sources

Immune checkpoint inhibitors in renal cell carcinoma [PDF]

open access: yes, 2017
The immune system has long been known to play a critical role in the body's defence against cancer, and there have been multiple attempts to harness it for therapeutic gain.
Jones, Robert J., Ross, Kirsty
core   +1 more source

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

open access: yesDermatology Research and Practice, 2010
Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported.
R. Rodríguez-Lojo   +7 more
doaj   +1 more source

Vaginal biocenosis in pregnant women with recurrent bacterial vaginosis after treatment with recombinant human interferon alpha-2b

open access: yesАкушерство, гинекология и репродукция, 2019
Introduction. Preventing recurrent bacterial vaginosis (BV) during pregnancy is an important issue in current obstetrics.Aim: to assess the effect of recombinant human interferon alpha-2b on the incidence of recurrent BV during pregnancy and on the ...
A. V. Podgornaya   +1 more
doaj   +1 more source

Immunogenicity of targeted lentivectors [PDF]

open access: yes, 2014
To increase the safety and possibly efficacy of HIV-1 derived lentivectors (LVs) as an anti-cancer vaccine, we recently developed the Nanobody (Nb) display technology to target LVs to antigen presenting cells (APCs).
Adotévi   +67 more
core   +3 more sources

Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C

open access: yesJournal of Infection in Developing Countries, 2015
Introduction: The WHO estimates that 180 million people are chronically infected with hepatitis C virus (HCV) throughout the world. Despite the emergence of new therapies, the combination of pegylated interferon and ribavirin remains the accepted ...
Jorge Luis Sandoval-Ramirez   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy